Login to Your Account



Other News To Note


Tuesday, September 10, 2013
Biolinerx Ltd., of Jerusalem, said the FDA granted orphan drug designation to BL-8040 to treat acute myeloid leukemia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription